This is going to start creeping upwards.. in the lead up to adult trials results, I suspect we edge towards the 50 cent mark. good results (expected), to take us to the 60-65 cent mark. fda submission 70-75 cent mark. slight retrace to the 58-65 cent mark as we wait. then $1.25-$1.50 shortly after fda approval, edging towards the $2.00 mark upon announcements relating to MOU's/Contracts.
Australia-China Biotech Invest 2017, page-12
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)